{"id":"https://openalex.org/W4416740644","doi":"https://doi.org/10.1158/1535-7163.30733833","title":"Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6, Table S1 from Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model","display_name":"Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6, Table S1 from Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model","publication_year":2025,"publication_date":"2025-11-27","ids":{"openalex":"https://openalex.org/W4416740644","doi":"https://doi.org/10.1158/1535-7163.30733833"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.30733833","doi":"https://doi.org/10.1158/1535-7163.30733833","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.30733833","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_Figure_S2_Figure_S3_Figure_S4_Figure_S5_Figure_S6_Table_S1_from_Upregulation_of_Somatostatin_Receptor_Type_2_Improves_sup_177_sup_Lu-DOTATATE_Therapy_in_Receptor-Deficient_Pancreatic_Neuroendocrine_Tumor_Model/30733833/1/files/59895594.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_Figure_S2_Figure_S3_Figure_S4_Figure_S5_Figure_S6_Table_S1_from_Upregulation_of_Somatostatin_Receptor_Type_2_Improves_sup_177_sup_Lu-DOTATATE_Therapy_in_Receptor-Deficient_Pancreatic_Neuroendocrine_Tumor_Model/30733833/1/files/59895594.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069800885","display_name":"Rupali Sharma","orcid":"https://orcid.org/0000-0002-0370-675X","observed_orcids":["https://orcid.org/0000-0002-0370-675X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rupali Sharma","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0370-675X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022252505","display_name":"Bhargav Earla","orcid":"https://orcid.org/0009-0000-4658-1945","observed_orcids":["https://orcid.org/0009-0000-4658-1945"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bhargav Earla","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-4658-1945","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018219579","display_name":"Kwamena E. Baidoo","orcid":"https://orcid.org/0009-0007-3726-1609","observed_orcids":["https://orcid.org/0009-0007-3726-1609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kwamena E. Baidoo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-3726-1609","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025622172","display_name":"Martha A. Zeiger","orcid":"https://orcid.org/0000-0001-8998-0858","observed_orcids":["https://orcid.org/0000-0001-8998-0858"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martha A. Zeiger","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8998-0858","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014881195","display_name":"James P. Madigan","orcid":"https://orcid.org/0000-0002-0503-3704","observed_orcids":["https://orcid.org/0000-0002-0503-3704"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James P. Madigan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0503-3704","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078610086","display_name":"Freddy E. Escorcia","orcid":"https://orcid.org/0000-0002-0727-3242","observed_orcids":["https://orcid.org/0000-0002-0727-3242"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Freddy E. Escorcia","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0727-3242","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5050780818","display_name":"Samira Mercedes Sadowski","orcid":"https://orcid.org/0000-0002-7538-9431","observed_orcids":["https://orcid.org/0000-0002-7538-9431"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samira M. Sadowski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7538-9431","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/somatostatin-receptor-2","display_name":"somatostatin receptor 2","score":0.9959999918937683},{"id":"https://openalex.org/keywords/177lu-dotatate","display_name":"177Lu-DOTATATE","score":0.9290000200271606},{"id":"https://openalex.org/keywords/pancreatic-neuroendocrine-tumors","display_name":"pancreatic neuroendocrine tumors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/receptor-deficiency","display_name":"receptor deficiency","score":0.6209999918937683},{"id":"https://openalex.org/keywords/radionuclide-therapy","display_name":"radionuclide therapy","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5834000110626221},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.520799994468689},{"id":"https://openalex.org/C32363146","wikidata":"https://www.wikidata.org/wiki/Q18031732","display_name":"Somatostatin receptor 3","level":5,"score":0.489300012588501},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.43720000982284546},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.42640000581741333},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3984000086784363},{"id":"https://openalex.org/C80115893","wikidata":"https://www.wikidata.org/wiki/Q2067077","display_name":"Somatostatin receptor","level":3,"score":0.39739999175071716},{"id":"https://openalex.org/C2778165163","wikidata":"https://www.wikidata.org/wiki/Q6084258","display_name":"Pancreatic neuroendocrine tumor","level":3,"score":0.35260000824928284},{"id":"https://openalex.org/C64980429","wikidata":"https://www.wikidata.org/wiki/Q18031730","display_name":"Somatostatin receptor 1","level":5,"score":0.34380000829696655},{"id":"https://openalex.org/C2776297358","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin","level":2,"score":0.33809998631477356},{"id":"https://openalex.org/C2910487530","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin Analogue","level":4,"score":0.33070001006126404},{"id":"https://openalex.org/C2779469564","wikidata":"https://www.wikidata.org/wiki/Q1920577","display_name":"MEN1","level":4,"score":0.3003999888896942},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.28360000252723694},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.26600000262260437},{"id":"https://openalex.org/C163258240","wikidata":"https://www.wikidata.org/wiki/Q25342","display_name":"Power (physics)","level":2,"score":0.2621000111103058},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2535000145435333}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.30733833","doi":"https://doi.org/10.1158/1535-7163.30733833","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.30733833","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_Figure_S2_Figure_S3_Figure_S4_Figure_S5_Figure_S6_Table_S1_from_Upregulation_of_Somatostatin_Receptor_Type_2_Improves_sup_177_sup_Lu-DOTATATE_Therapy_in_Receptor-Deficient_Pancreatic_Neuroendocrine_Tumor_Model/30733833/1/files/59895594.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30733833","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Figure_S1_Figure_S2_Figure_S3_Figure_S4_Figure_S5_Figure_S6_Table_S1_from_Upregulation_of_Somatostatin_Receptor_Type_2_Improves_sup_177_sup_Lu-DOTATATE_Therapy_in_Receptor-Deficient_Pancreatic_Neuroendocrine_Tumor_Model/30733833","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.30733833","doi":"https://doi.org/10.1158/1535-7163.30733833","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.30733833","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_Figure_S2_Figure_S3_Figure_S4_Figure_S5_Figure_S6_Table_S1_from_Upregulation_of_Somatostatin_Receptor_Type_2_Improves_sup_177_sup_Lu-DOTATATE_Therapy_in_Receptor-Deficient_Pancreatic_Neuroendocrine_Tumor_Model/30733833/1/files/59895594.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416740644.pdf","grobid_xml":"https://content.openalex.org/works/W4416740644.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386485338","https://openalex.org/W4386475082","https://openalex.org/W4386485351","https://openalex.org/W4385212580","https://openalex.org/W4386485051","https://openalex.org/W4293236675","https://openalex.org/W4367842937","https://openalex.org/W2003363281","https://openalex.org/W1981002414","https://openalex.org/W2474863315"],"abstract_inverted_index":{"Supplementary":[0],"Figures":[1],"and":[2],"Tables":[3],"with":[4],"Legend":[5]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-11-28T00:00:00"}